These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31132233)

  • 21. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
    Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
    Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
    Xu Y; Li Q; Lin Z; Lin Y
    Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
    Chen W; Li Y; Yuan D; Peng Y; Qin J
    Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.
    Zhou S; Wang L; Zhang W; Liu F; Zhang Y; Jiang B; Wang J; Yuan H
    Technol Cancer Res Treat; 2021; 20():1533033821990037. PubMed ID: 33641530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer.
    Feng M; Ye X; Chen B; Zhang J; Lin M; Zhou H; Huang M; Chen Y; Zhu Y; Xiao B; Huang C; Katz RL; Bai C
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2397-2405. PubMed ID: 33547948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
    Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
    J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
    Zhou J; Dong F; Cui F; Xu R; Tang X
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
    Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
    Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
    Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and Diagnostic Values of Circulating Tumor Cells and Tumor Markers for Lung Cancer.
    Liu X; Wang C; Zhang L; Gu H; Yang J; Wang Y; Tan J
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
    Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
    Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
    Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].
    Lian H; Ding Z; Yuan D; Ma J; Qin J
    Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):813-820. PubMed ID: 27978866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cluster circulating tumor cells in surgical cases of lung cancer.
    Sawabata N; Susaki Y; Nakamura T; Kawaguchi T; Yasukawa M; Taniguchi S
    Gen Thorac Cardiovasc Surg; 2020 Sep; 68(9):975-983. PubMed ID: 32043230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
    Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.